Israeli Researchers Developing Morning-After-Pill For PTSD

Israeli Researchers Developing Morning-After-Pill For PTSD

An initial clinical trial conducted on 24 people involved in traffic accidents seems to corroborate earlier animal experiments indicating that it may be possible to develop a "morning-after pill" to prevent the development of post-traumatic stress disorder. The Israeli researchers who conducted the trial determined that the administration of a hormone reduces the risk of developing PTSD by 80 percent.

Popular in the Community

Close

What's Hot